Stability of Mycobacterium tuberculosis DNA genotypes

The Journal of Infectious Diseases
R W YehPeter M Small

Abstract

To assess genotype stability in Mycobacterium tuberculosis, DNA genotypes were compared in sequential isolates from 49 patients who had sputum cultures separated by at least 90 days that grew M. tuberculosis. By use of IS6110 and the polymorphic GC-rich sequence (PGRS) as markers, it was found that paired isolates from 14 (29%) of 49 patients showed changes in their DNA genotypes between isolates (12 in IS6110 genotypes and 2 in PGRS genotypes). Changed IS6110 genotypes were confined to strains with 8-14 bands and were not related to the bacterial drug susceptibility, the patients' human immunodeficiency virus serostatus, or adherence to therapy. Although this rate of change complicates the interpretation of molecular epidemiologic studies, it can be exploited to gain additional insight into disease transmission. Furthermore, IS6110-related mutations may be a major source of genetic plasticity in M. tuberculosis and provide insights into the organism's evolution and virulence.

Citations

Feb 24, 2001·Social Science & Medicine·A S KlovdahlJ M Musser
Feb 13, 2007·Epidemiology and Infection·P FarniaA A Velayati
Jun 28, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Annika KrüünerMarika Mikelsaar
Apr 19, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jessie TorgersenWendy Cronin
May 24, 2001·Current Opinion in Pulmonary Medicine·H A Fletcher
Jun 15, 2006·Respirology : Official Journal of the Asian Pacific Society of Respirology·Moira Chan-YeungCheuk-Ming Tam
Oct 17, 2006·Clinical Microbiology Reviews·Barun MathemaBarry N Kreiswirth
Dec 10, 2003·Journal of Clinical Microbiology·G D van der SpuyP D van Helden
Jun 7, 2003·Journal of Clinical Microbiology·Moira Chan-YeungKai-Man Kam
Mar 9, 2004·Journal of Clinical Microbiology·Madalene RichardsonRobin M Warren
Jun 9, 2004·Journal of Clinical Microbiology·Paul H C EilersMartien W Borgdorff
Mar 8, 2005·Journal of Clinical Microbiology·S SamperUNKNOWN Spanish Working Group on MDR-TB
Jan 24, 2004·Occupational and Environmental Medicine·A SeidlerR Diel
Feb 15, 2014·BioMed Research International·Tomasz JagielskiJacek Bielecki
Mar 19, 2002·American Journal of Respiratory and Critical Care Medicine·Charles L Daley
Oct 19, 2011·The European Respiratory Journal·Marieke J van der WerfDavide Manissero
Sep 10, 2004·BMC Evolutionary Biology·Mark M Tanaka
Mar 4, 2011·Future Microbiology·Midori Kato-MaedaLaura Flores
Apr 30, 1999·Emerging Infectious Diseases·N HoeJ M Musser
Nov 28, 2002·Emerging Infectious Diseases·Ann C MillerSue Etkind
Feb 27, 2003·Emerging Infectious Diseases·Emilia VynnyckyPaul E M Fine
Feb 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·E MazarsP Supply
Mar 26, 2004·Proceedings of the National Academy of Sciences of the United States of America·Aaron E HirshPeter M Small
May 16, 2000·Chest·M Lauzardo, D Ashkin
Feb 14, 2012·The Journal of Infection·Ewa Augustynowicz-KopećZofia Zwolska
Mar 26, 2008·Revista portuguesa de pneumologia·Isabel PortugalLaura Brum

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.